- Open
- 1.05
- High
- 1.09
- Low
- 1.03
- Close
- 1.03
- Change
- -0.05 (-4.76%)
- Volume
- 483,548
| 14 Jul 2026 | 07:00:05 | Board Appointment |
| 13 Jul 2026 | 07:00:09 | Trading Update |
| 10 Jul 2026 | 07:00:04 | UK Minister highlights pharmacogenetic testing |
| 1 Jul 2026 | 07:00:05 | Board change |
| 29 Jun 2026 | 07:00:09 | CYP2C19 Agreement with Thermo Fisher Scientific |
| 22 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 23 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 2 Jan 2024 | Annual Report and Accounts (to 2023-06-30) |
genedrive plc is a company that specializes in molecular diagnostics. They are focused on creating a point-of-need platform that is affordable, fast, flexible, user-friendly, and reliable. This platform is designed to diagnose infectious diseases, as well as to help with patient stratification, pathogen detection, and other medical needs.
| 14 Jul 2026 | 07:00:05 | Board Appointment |
| 13 Jul 2026 | 07:00:09 | Trading Update |
| 10 Jul 2026 | 07:00:04 | UK Minister highlights pharmacogenetic testing |
| 1 Jul 2026 | 07:00:05 | Board change |
| 29 Jun 2026 | 07:00:09 | CYP2C19 Agreement with Thermo Fisher Scientific |
| 22 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 23 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 2 Jan 2024 | Annual Report and Accounts (to 2023-06-30) |
genedrive plc is a company that specializes in molecular diagnostics. They are focused on creating a point-of-need platform that is affordable, fast, flexible, user-friendly, and reliable. This platform is designed to diagnose infectious diseases, as well as to help with patient stratification, pathogen detection, and other medical needs.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £108m | +0.4% | |
| £59m | -0.3% | |
| £25m | +0.6% | |
GDRGenedrive PLC | £11m | -0.2% |
| £9m | +0.3% | |
| £1m | — |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £108m | +0.4% | |
| £59m | -0.3% | |
| £25m | +0.6% | |
GDRGenedrive PLC | £11m | -0.2% |
| £9m | +0.3% | |
| £1m | — |